Markus Engelhard is active in all fields of life sciences, pharmacology, and biotechnology, having a particular focus on therapeutic biomolecules and pharmaceutically active agents. His clients include start-up companies, small and medium-sized enterprises, multinational corporations, universities, and academic research institutions. He supports them in acquiring and enforcing intellectual property rights, building up patent portfolios, and representing them in opposition, invalidation, and infringement proceedings. Moreover, he provides professional advice to international organizations, government agencies, and technology transfer agencies.
Markus Engelhard was a scholar of the Studienstiftung des deutschen Volkes and studied biology, chemistry, and biochemistry at the University of Cambridge, UK, the University of Frankfurt am Main, and the University of Witten-Herdecke. After graduation, he obtained his PhD with an Oliver Gatty Studentship from the Department of Biochemistry of the University of Cambridge, where he was a postdoctoral fellow in research and teaching.